VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,458 | +5844.0% | 1,032 | +23.7% | 0.00% | -100.0% |
Q2 2023 | $75 | -70.9% | 834 | -97.5% | 0.01% | +300.0% |
Q4 2022 | $258 | -99.9% | 33,847 | -21.9% | 0.00% | -50.0% |
Q3 2022 | $450,000 | -18.9% | 43,356 | -9.8% | 0.00% | -20.0% |
Q2 2022 | $555,000 | +3.4% | 48,071 | +0.8% | 0.01% | +25.0% |
Q1 2022 | $537,000 | -21.3% | 47,706 | +2.5% | 0.00% | -20.0% |
Q4 2021 | $682,000 | -60.4% | 46,526 | -54.6% | 0.01% | -50.0% |
Q3 2021 | $1,722,000 | +115.8% | 102,467 | +97.1% | 0.01% | +100.0% |
Q2 2021 | $798,000 | -15.1% | 51,998 | -6.1% | 0.01% | -16.7% |
Q1 2021 | $940,000 | +15.1% | 55,398 | -3.7% | 0.01% | +20.0% |
Q4 2020 | $817,000 | +39.7% | 57,553 | +0.9% | 0.01% | +25.0% |
Q3 2020 | $585,000 | -5.8% | 57,056 | -0.1% | 0.00% | -20.0% |
Q2 2020 | $621,000 | +0.6% | 57,107 | +10.5% | 0.01% | -16.7% |
Q1 2020 | $617,000 | -5.2% | 51,683 | +3.2% | 0.01% | +20.0% |
Q4 2019 | $651,000 | -5.1% | 50,074 | +0.1% | 0.01% | 0.0% |
Q3 2019 | $686,000 | +4.1% | 50,009 | +0.8% | 0.01% | 0.0% |
Q2 2019 | $659,000 | -29.0% | 49,604 | -4.3% | 0.01% | -37.5% |
Q1 2019 | $928,000 | -36.4% | 51,842 | +1.4% | 0.01% | -33.3% |
Q4 2018 | $1,458,000 | – | 51,117 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |